士卓曼集团

描述

Evidence Based Practice Webinar Series 2026

Criteria for immediate treatment protocols?

Speaker: Eirik Aasland Salvesen, DDS, CEO Oris Dental

Wedenesday 16 June

17-18 (CET)

he primary goals of implant treatment, as defined by Buser and coworkers, are successful treatment outcome, high predictability, good long-term stability and low complication rate. These goals ensures the benchmarking of a specific protocol or product. 

The secondary goals of implant treatment are fewest possible number of surgical interventions, low pain and morbidity during healing, short healing periods and short overall treatment time. These goals ensure that we also take into account the patient experience when choosing the appropriate individual treatment approach. Does immediate treatment protocols really offer a chance to obtain both the primary and secondary goals? 

By the end of this webinar, you will:

• Understand the difference between conventional and immediate protocols
• Understand the benefits and limitations of the different approaches
• Know more about case selection for immediate procedures
• Understand the needs for introducing immediate protocols in your clinical practice.

ABOUT THE SPEAKER:

EIRIK AASLAND SALVESEN, DDS, CEO Oris Dental 

Dr Salvesen graduated from the University of Bergen in 1999 and specialized in Periodontology. He is the co-founder and CEO of Oris Dental, responsible for more than 140 clinics and labs in Norway, Sweden and Denmark. Since 2004 Salvesen has lectured worldwide on dental implants, periodontology and hard & soft tissue augmentation. He is a long-time ITI fellow and has more recently been involved in product development with Straumann. Salvesen is widely known within the global community professionals as a proponent of immediate treatment protocols and the focus on the patient journey.

目标人群: 牙医, 口腔正畸医师

产品分类: Implantology

提供者: Straumann AB
Krokslätts Fabriker 45
431 37 Mölndal, 瑞典

电话: +46 31 708 7500
传真: +46 31 708 7529
电子邮件: education.se@straumann.com